Drug Store News

Breckenridge obtains FDA OK for generic Eliquis

Eliquis had a market value of $14 billion during the 12 months ended May 2021, according to industry data. The Food and Drug Administration has cleared Breckenridge’s apixaban tablets. The medication ...
The Pharma Letter

Eliquis sales forecast to fall by 15.2% in 2026 as European patent expiry nears

Global sales of Bristol Myers Squibb’s and Pfizer’s drug Eliquis (apixaban) are projected to decline by 15.2% in 2026 due to ...
NBC Washington

Here are the first 10 drugs the government will negotiate lower prices for to cut Medicare costs

The popular diabetes treatment Jardiance and the blood thinner Eliquis are among the first drugs that will be targeted for price negotiations in effort to cut Medicare costs. President Joe Biden's ...
BioSpace

BMS Beats Again Despite Eliquis and Cobenfy Disappointments

Bristol Myers Squibb delivered better than expected fourth quarter earnings, but Eliquis missed expectations while Cobenfy ...
Morningstar

TAHO Pharma Announces Submission of New Drug Application (NDA) to the U.S. FDA for TAH3311 - The World's First Apixaban Oral Dissolving Film - Represents a Transformational ...

TAIPEI, Oct. 1, 2025 /PRNewswire/ -- TAHO Pharmaceuticals Ltd. ("TAHO Pharma") today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ...
Washington Examiner

FDA clears anticlotting drug Eliquis

WASHINGTON (AP) — The Food and Drug Administration said Friday that it approved an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc. It’s a potential blockbuster ...